Cardiovascular Diseases Clinical Trial
Official title:
Cardial-MASS-Study: Influencing Factors on Reliability of Selfreported Weight and Height in Patients With Cardiovascular Disease
Height and weight are important informations in clinical life. Medication is dosed by them and weight, especially overweight, is a risk factor for cardiovascular diseases. Mostly you have to rely on the self-reported informations, because there is plenty of work and little time to weigh and measure every patient. But can the investigators really trust this informations? Former studies have shown, that most of self-reported heights and weights differ from the measured ones. This fact might lead to a wrong dosage of medicine or underestimated risk factors. So the Cardial-MASS-Study tries to detect influencing factors on the reliability of self-reported informations especially among patients, treated at the cardiological department at Saarland University.
Weight and height of patients is often recorded in clinical practice, as well as in clinical
research. They give important informations for medication dosages, e.g., anticoagulants or
anesthesias. Furthermore, the body mass index (BMI), calculated by weight and height, is an
easy instrument to estimate a patient`s risk for cardiovascular diseases based on obesity.
In clinical practice, informations about height and weight do often rely on self-reported
values instead of measured ones. This can be due to limited timely, but also instrumental
resources, when scales or measuring tapes are not available. Unfortunately, these
self-reported informations are often inaccurate. Age, education, weight, and sex seam to
influence and distort them in different ways.
Former studies have shown, that a lot of patients overestimate their height [1-8] and
underestimate their weight [1-6]. This might lead to a wrong classification in normal weight
and overweight using BMI. Among elderly (>60 years) informations relying on measured values
and on self-reported values seem to be even more divergent [10].
People with overweight are tending to underestimate their weight stronger than people with
normal weight. The higher the weight, the more the self-reported information deviates from
the actual weight [11,12]. Men`s informations are more exact than women`s, like Niedhammer et
al. has shown in a study with 7350 participants [9]. Men with a BMI lower than 25 even
overestimated their weight. Compared to younger ones, elderly men underestimated their weight
more often, and elderly women`s self-reported weight was more accurate [1,9].
Next to age and gender, socioeconomic variables do influence self-reported measures. The
higher the education or working position the more accurate the information about height.
Noteworthy, women in high working positions overestimate their height, when compared to women
in lower positions, who even underestimate their height [2,5,6,8,9].
Furthermore, external conditions of data acquisition may impact validity of self-reported
information, too. Stewart supposed that informations given in an interview are more exact
than those given in a questionnaire [11].
Most of the studies mentioned above are not exclusively related to patients with
cardiovascular diseases. Studies referring to this patient population suggest, that men with
cardiovascular diseases underestimate their weight less than others [13]. Nevertheless,
Niedhammer et al. could not confirm this finding [9]. HEnce, the aim of this study is to
identify factors that influence the validity of self-reported height and weight in patients
with cardiovascular disease.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|